InvestorsHub Logo
Followers 69
Posts 7613
Boards Moderated 0
Alias Born 01/10/2014

Re: crescentmotor post# 405465

Thursday, 03/02/2023 1:57:14 AM

Thursday, March 02, 2023 1:57:14 AM

Post# of 462468
Simufilam only targets Alzheimer is correct. Blarcamesine on the other hand currently has other indications in the pipeline and more to come.

"Simufilam is a proprietary, small molecule (oral) drug that restores the normal shape and function of altered filamin A (FLNA), a scaffolding protein, in the brain."

"We are now in clinical studies to test a new and promising scientific approach for the treatment and diagnosis of Alzheimer's disease."

https://www.cassavasciences.com/pti-125

If there were other indications one would think they would be mentioned by the company.

My $AVXL to $SAVA ratio is more like 700 to 1, but your plan works too.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News